To investigate whether the activation of cGAS/STING pathway participates in the anti-tumor effect of Trabid deficiency, we treated mice inoculated with Trabid-deficient B16F10 cells with a STING inhibitor C176. Here, ZRANB1 is linked to neoplasm.